BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15231710)

  • 21. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
    Soria JC; Lee HY; Lee JI; Wang L; Issa JP; Kemp BL; Liu DD; Kurie JM; Mao L; Khuri FR
    Clin Cancer Res; 2002 May; 8(5):1178-84. PubMed ID: 12006535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter.
    Pore N; Liu S; Haas-Kogan DA; O'Rourke DM; Maity A
    Cancer Res; 2003 Jan; 63(1):236-41. PubMed ID: 12517803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of PTEN (phosphatase and tensin homolog deleted on chromosome 10) expression by estradiol and progesterone in human endometrium.
    Guzeloglu-Kayisli O; Kayisli UA; Al-Rejjal R; Zheng W; Luleci G; Arici A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):5017-26. PubMed ID: 14557489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN and Egr-1 expression in thyroid proliferative lesions.
    Di Loreto C; Tell G; Pestrin M; Pandolfi M; Damante G; Puglisi F
    Cancer Lett; 2005 Jun; 224(1):105-9. PubMed ID: 15911105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning of the single strand DNA-binding protein important for maximal expression and thyrotropin (TSH)-induced negative regulation of the TSH receptor.
    Ohmori M; Ohta M; Shimura H; Shimurat Y; Suzuki K; Kohn LD
    Mol Endocrinol; 1996 Nov; 10(11):1407-24. PubMed ID: 8923467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ceramide and protein kinase C on the regulation of type I 5'-deiodinase in FRTL-5 rat thyroid cells.
    Mori K; Stone S; Braverman LE; DeVito WJ
    Endocrinology; 1996 Nov; 137(11):4994-9. PubMed ID: 8895373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells.
    Kogai T; Endo T; Saito T; Miyazaki A; Kawaguchi A; Onaya T
    Endocrinology; 1997 Jun; 138(6):2227-32. PubMed ID: 9165005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis.
    Gomez-Manzano C; Fueyo J; Jiang H; Glass TL; Lee HY; Hu M; Liu JL; Jasti SL; Liu TJ; Conrad CA; Yung WK
    Ann Neurol; 2003 Jan; 53(1):109-17. PubMed ID: 12509854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The tumor suppressor PTEN inhibits EGF-induced TSP-1 and TIMP-1 expression in FTC-133 thyroid carcinoma cells.
    Soula-Rothhut M; Coissard C; Sartelet H; Boudot C; Bellon G; Martiny L; Rothhut B
    Exp Cell Res; 2005 Mar; 304(1):187-201. PubMed ID: 15707585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ceramide regulation of the tumor suppressor phosphatase PTEN in rafts isolated from neurotumor cell lines.
    Goswami R; Singh D; Phillips G; Kilkus J; Dawson G
    J Neurosci Res; 2005 Aug; 81(4):541-50. PubMed ID: 15968641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways.
    Liu W; Asa SL; Fantus IG; Walfish PG; Ezzat S
    Am J Pathol; 2002 Feb; 160(2):511-9. PubMed ID: 11839571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the cyclic adenosine 3',5'-monophosphate response element in efficient expression of the rat thyrotropin receptor promoter.
    Ikuyama S; Shimura H; Hoeffler JP; Kohn LD
    Mol Endocrinol; 1992 Oct; 6(10):1701-15. PubMed ID: 1333054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
    Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
    Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
    Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
    Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid-specific expression and cyclic adenosine 3',5'-monophosphate autoregulation of the thyrotropin receptor gene involves thyroid transcription factor-1.
    Shimura H; Okajima F; Ikuyama S; Shimura Y; Kimura S; Saji M; Kohn LD
    Mol Endocrinol; 1994 Aug; 8(8):1049-69. PubMed ID: 7997232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
    Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S
    Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression.
    Balducci-Silano PL; Suzuki K; Ohta M; Saito J; Ohmori M; Montani V; Napolitano G; Shong M; Taniguchi SI; Pietrarelli M; Lavaroni S; Mori A; Singer DS; Kohn LD
    Endocrinology; 1998 May; 139(5):2300-13. PubMed ID: 9564838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single strand DNA-binding proteins and thyroid transcription factor-1 conjointly regulate thyrotropin receptor gene expression.
    Shimura H; Shimura Y; Ohmori M; Ikuyama S; Kohn LD
    Mol Endocrinol; 1995 May; 9(5):527-39. PubMed ID: 7565801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-apoptotic action of (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378) by suppression of the phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and increased phosphorylation of casein kinase2/Akt/ cyclic AMP response element binding protein via maxi-K channel opening in neuronal cells.
    Kim KY; Lee JH; Park JH; Yoo MA; Kwak YG; Kim SO; Yoo SE; Hong KW
    Eur J Pharmacol; 2004 Aug; 497(3):267-77. PubMed ID: 15336944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.